• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

NFkB p65 Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS440031

Members of the rel/NFkB family of transcription factors are involved in the regulation of cellular responses, such as growth, development, and the inflammatory response. They share a structural motif known as the rel homology region (RHR), the C-terminal one… More details

$325 / 0.2 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
NFkB p65, Polyclonal Antibody
Full Product Name
NFkB p65 (C20) Antibody
Product Gene Name
Clonality
Polyclonal
Host
Rabbit
Form/Format
Each vial contains 200 ug/ml of affinity-purified rabbit IgG, NFkB p65 MBS440031 (C20), in 1 ml PBS containing 0.1% sodium azide and 0.2% gelatin.
Specificity
NFkB p65 (C20) MBS440031, reacts with NFkB p65 of mouse, rat and human origin by Western Blotting, immunoprecipitation and immunohistchemistry. Western Blotting starting dilution: 1:400-1:1000.
Preparation and Storage
Store this product at 4°C, do not freeze. The product is stable for one year from the date of receipt.
Antibody/Peptide Pairs
NFkB p65 peptide (MBS443031) is used for blocking the activity of NFkB p65 antibody (MBS440031)
Source
NFkB p65 (C20) is provided as an affinity purified rabbit polyclonal antibody, raised against a peptide mapping to the carboxy terminus of human NFkB p65.
Competition Studies
A blocking peptide is also available, MBS443031, for use in competition studies. Each vial contains 100ug of peptide in 0.5ml PBS 0.1% sodium azide and 100 ug BSA.
Application Notes for anti-NFkB p65 antibody
Western blotting starting dilution: 1:400-1:1000.

Immunohistochemistry (IHC) of anti-NFkB p65 antibody

Rabbit Anti-NFkB p65 Polyclonal Antibody – Cat# MBS440031

Product References and Citations for anti-NFkB p65 antibody

1.) Leitch D, Barrans SL, Jack AS, Owen RG. 2003. Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation. Semin Oncol. Apr;30(2):161-4.2.) Stjernholm-Vladic Y, Stygar D, Mansson C, Masironi B, Akerberg S, Wang H, Ekman-Ordeberg G, and Sahlin L. 2004. Factors involved in the inflammatory events of cervical ripening in humans. Reproductive Biology & Endocrinology 2:74.3.) Lee KW, Lee Y, Kwon HJ and Kim DS. 2005. Sp1-associated activation of macrophage inflammatory protein-2 promoter by CpG-oligodeoxynucleotide and lipopolysaccharide. Cell and Molecular Life Sciences 62:188-198. 4.)Joo SS, Won TJ, Lee do I. Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch Pharm Res. 2004 Sep;27(9):954-60. 5.) Popov Y, Patsenker E, Bauer M, Niedobitek E, Schulze-Krebs A, Schuppan D. 2006. Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB. J Biol Chem. 281(22):15090-8.6.) Longpré F, Garneau P, Christen Y, Ramassamy C. 2006. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med. Dec 15;41(12):1781-94. 7.) Kang HB, Kim YE, Kwon HJ, Sok DE, Lee Y. 2007. Enhancement of NF-kappaB expression and activity upon differentiation of human embryonic stem cell line SNUhES3. Stem Cells Dev. 2007 Aug;16(4):615-23.8.) Lee KW, Lee Y, Kim DS, Kwon HJ. 2006. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression. Eur J Immunol. May;36(5):1254-66.9.) Fan Z, Söder S, Oehler S, Fundel K, Aigner T. 2007. Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am J Pathol. Sep;171(3):938-46.

1. Lentsch AB, Ward PA. The NFkappaBb/IkappaB system in acute inflammation. Arch Immunol Ther Exp (Warsz). 48(2): 59-63. 2. Hatada EN, Krappmann D, Scheidereit C. NF-kappaB and the innate immune response. Curr Opin Immunol. 2000 Feb; 12(1): 52-8 3. Ho E, Bray TM. Antioxidants, NFkappaB activation, and diabetogenesis. Proc Soc Exp Biol Med. 1999 Dec; 222(3): 205-13.4. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 2001 Aug; 38(2): 307-14.5. Chen FE, Kempiak S, Huang DB, Phelps C, Ghosh G. Construction, expression, purification and functional analysis of recombinant NFkappaB p50/p65 heterodimer. Protein Eng. 1999 May; 12(5): 423-8.6. Sengchanthalangsy LL, Datta S, Huang DB, Anderson E, Braswell EH, Ghosh G. Characterization of the dimer interface of transcription factor NFkappaB p50 homodimer. J Mol Biol. 1999 Jun 18; 289(4): 1029-40.7. Huang DB, Huxford T, Chen YQ, Ghosh G. The role of DNA in the mechanism of NFkappaB dimer formation: crystal structures of the dimerization domains of the p50 and p65 subunits. Structure. 1997 Nov 15; 5(11): 1427-36.8. Magnani M, Crinelli R, Bianchi M, Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets. 2000 Dec; 1(4): 387-99.

Other Notes

Small volumes of anti-NFkB p65 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for NFkB p65 purchase

MBS440031 is an antibody targeting NFkB p65. Also known as NFkB p65 (C20) Antibody. Host: Rabbit.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000